Ratings Aedifica SA

Equities

AED

BE0003851681

Real-time Euronext Bruxelles Other stock markets 11:00:20 2024-05-09 am EDT			5-day change	1st Jan Change
63.55 ^EUR	+0.16%		+2.25%	-0.16%

May. 02	Aedifica NV/SA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 02	Aedifica NV/SA Provides Earnings Guidance for the Year 2024	CI

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
The company presents an interesting fundamental situation from a short-term investment perspective.
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The company's share price in relation to its net book value makes it look relatively cheap.
This company will be of major interest to investors in search of a high dividend stock.
For several months, analysts have been revising their EPS estimates roughly upwards.

Weaknesses

One of the major weak points of the company is its financial situation.
The company's "enterprise value to sales" ratio is among the highest in the world.
For the past year, analysts have significantly revised downwards their profit estimates.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

	1st Jan change	Capi.	ESG Refinitiv
AEDIFICA SA	-0.16%	3.24B	B+
WELLTOWER INC.	+8.96%	58.83B	A-
VENTAS, INC.	-5.24%	19.2B	A-
HEALTHPEAK PROPERTIES, INC.	-3.03%	13.48B	A
OMEGA HEALTHCARE INVESTORS, INC.	+0.55%	7.62B	B
HEALTHCARE REALTY TRUST INCORPORATED	-13.64%	5.84B	B-
CARETRUST REIT, INC.	+10.57%	3.53B	C-
SABRA HEALTH CARE REIT, INC.	+1.16%	3.44B	C+
NATIONAL HEALTH INVESTORS, INC.	+17.33%	2.85B	C-
MEDICAL PROPERTIES TRUST, INC.	-8.45%	2.7B	C

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes